CD8A and cancer: As a result, this approach cannot resolve the cellular source or spatial localization of the measured proteins: whether CD155 derives predominantly from malignant epithelial cells, cancer-associated fibroblasts/endothelium, or tumor-associated macrophages, and whether TIGIT reflects exhausted CD8+ T cells, Tregs, or other lymphocyte compartments.